CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist

28.89
+0.09+0.31%

Not Open Dec 19 15:00 CST

46.97BMarket Cap13.72P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-13.52%17.19B

-22.31%16.23B

-2.43%19.75B

-5.29%21.31B

-8.30%19.87B

-7.37%20.89B

-14.12%20.25B

0.55%22.5B

-9.52%21.67B

2.07%22.55B

Transactional financial assets

-75.38%14M

-92.97%4M

12.24%56.87M

468.73%56.87M

--56.87M

1,166.71%50.67M

153.34%50.67M

Notes receivable and accounts receivable

0.28%17.34B

1.36%17.41B

1.69%17.49B

-0.01%15.98B

5.81%17.3B

9.03%17.18B

13.66%17.2B

13.86%15.98B

14.93%16.35B

6.96%15.75B

-Notes receivable

-14.58%661.65M

-35.72%689.74M

-37.87%777.48M

-22.75%870.88M

-34.67%774.56M

-15.05%1.07B

-1.13%1.25B

-7.75%1.13B

28.51%1.19B

-3.89%1.26B

-Accounts receivable

0.97%16.68B

3.83%16.72B

4.79%16.72B

1.72%15.11B

8.97%16.52B

11.13%16.1B

15.01%15.95B

15.93%14.86B

13.99%15.16B

8.02%14.49B

Other receivables (including interest and dividends)

-9.93%971.41M

18.31%1.06B

-5.44%1.12B

-4.23%878.49M

3.19%1.08B

-18.08%895.1M

-4.76%1.18B

-22.18%917.24M

1.81%1.05B

4.93%1.09B

-Dividend receivable

-98.57%1.5M

-96.70%1.5M

-72.00%61.26M

-51.93%105.16M

-86.79%45.4M

-36.36%218.77M

45.84%218.77M

129.18%343.77M

-Other receivable

----

24.46%1.06B

----

13.46%849.7M

----

-16.34%698.48M

----

-15.98%748.91M

Advance payment

-24.42%648.23M

25.01%708.49M

95.23%982.77M

-2.12%818.36M

38.32%857.65M

-8.57%566.75M

-18.08%503.4M

7.29%836.05M

-10.83%620.05M

-1.61%619.87M

Inventories

17.46%11.34B

17.34%10.75B

10.10%9.85B

7.83%11.51B

14.43%9.66B

11.85%9.16B

2.45%8.95B

2.24%10.67B

-1.59%8.44B

0.37%8.19B

Receivable financing

32.20%3.69B

22.97%3.93B

9.02%5.08B

13.56%3.61B

6.86%2.79B

21.81%3.2B

33.68%4.66B

0.34%3.18B

-1.34%2.61B

-4.53%2.62B

Non-current assets due within one year

207.52%272.58M

-57.64%254.95M

-48.94%283.96M

-75.60%159.36M

-86.31%88.64M

451.75%601.9M

--556.08M

--653.12M

--647.53M

--109.09M

Other current assets

28.96%1.58B

24.88%1.6B

-33.04%1.4B

-24.42%1.71B

-13.98%1.22B

-14.66%1.28B

275.88%2.09B

173.39%2.26B

173.06%1.42B

194.65%1.5B

Total current assets

0.24%53.05B

-3.49%51.94B

0.94%55.96B

-1.89%55.98B

0.13%52.92B

2.54%53.82B

3.92%55.44B

8.05%57.06B

2.35%52.86B

5.13%52.49B

Non Current assets

Debt investment

46.62%9.57B

112.40%9.53B

69.37%6.45B

106.55%6.54B

122.56%6.53B

452.74%4.48B

346.58%3.81B

401.73%3.16B

369.29%2.93B

31.09%811.31M

Other equity investment

-0.67%104.4M

-1.35%104.19M

-5.46%104.48M

-5.26%103.81M

-9.69%105.1M

-15.83%105.62M

-12.34%110.51M

-11.22%109.57M

-27.82%116.38M

-22.29%125.48M

Other non-current financial assets

89.74%1.02B

-0.56%1.01B

-3.67%1.01B

-3.17%1.01B

-53.93%539.35M

0.32%1.01B

80.12%1.05B

80.89%1.04B

360.69%1.17B

307.63%1.01B

Investment real estate

11.36%147.66M

10.12%146.78M

-26.58%150.06M

-17.87%169.77M

-36.39%132.6M

-36.36%133.3M

-3.72%204.39M

-3.40%206.71M

-13.58%208.45M

-2.78%209.47M

Long-term equity investment

7.51%1.93B

-1.41%1.8B

23.62%1.83B

13.99%1.81B

8.38%1.79B

12.22%1.83B

-7.48%1.48B

1.36%1.58B

-11.54%1.65B

-11.26%1.63B

Fixed assets

----

13.92%4.42B

----

11.34%3.88B

----

10.80%3.71B

----

19.47%3.49B

Constru in process

----

25.06%2.69B

----

27.78%2.15B

----

34.80%2.11B

----

13.20%1.68B

Productive biological assets

-15.93%1.84M

-15.32%1.93M

-14.76%2.02M

-14.23%2.11M

-13.74%2.19M

-13.29%2.28M

-12.86%2.37M

-12.46%2.46M

-12.08%2.54M

-11.73%2.63M

Intangible assets

8.41%2.84B

8.61%2.86B

11.60%2.87B

11.66%2.89B

2.86%2.62B

2.74%2.63B

0.03%2.57B

0.10%2.59B

5.13%2.55B

5.50%2.56B

Development expenditure

38.53%366.38M

37.39%351.78M

31.98%333.02M

28.76%309.89M

1,811.46%264.48M

1,570.14%256.04M

1,832.90%252.33M

2,177.44%240.67M

54.00%13.84M

102.62%15.33M

Goodwill

0.17%830.85M

0.00%829.47M

0.47%829.47M

Long deferred expense

-3.26%188.72M

3.69%184.89M

10.43%185.74M

13.84%189.88M

38.36%195.08M

27.11%178.31M

24.49%168.2M

25.91%166.8M

27.00%141M

24.71%140.28M

Deferred tax assets

24.33%1.17B

10.55%1.22B

33.50%1.19B

34.46%1.16B

15.69%940.69M

32.75%1.1B

12.38%892.5M

8.95%865.34M

5.82%813.13M

8.70%830.88M

Usufruct assets

-21.03%637.56M

-7.66%676.54M

-9.20%706.32M

-2.83%728.9M

16.50%807.35M

-3.88%732.66M

2.57%777.86M

-2.56%750.16M

-17.26%693.02M

-11.62%762.26M

Other non current assets

-54.22%206.17M

-54.05%210.45M

-6.77%212.67M

-63.96%86.45M

104.35%450.33M

112.09%458.04M

4.64%228.13M

42.35%239.83M

14.15%220.37M

18.24%215.97M

Total non current assets

22.29%26.21B

31.55%26.03B

24.82%22.74B

28.42%22.6B

28.36%21.43B

38.26%19.79B

33.02%18.22B

32.27%17.6B

28.99%16.69B

12.96%14.31B

Total assets

6.59%79.26B

5.93%77.97B

6.85%78.7B

5.25%78.59B

6.90%74.35B

10.19%73.61B

9.87%73.66B

12.93%74.67B

7.69%69.55B

6.71%66.8B

Liabilities

Current liabilities

Short term loan

15.36%9.41B

8.14%9.24B

9.98%9.48B

-8.66%7.8B

-3.20%8.16B

-3.96%8.55B

-10.85%8.62B

1.31%8.54B

-7.07%8.43B

-13.34%8.9B

Notes payable and accounts payable

1.23%16.35B

1.84%15.29B

4.11%15.14B

4.85%15.69B

6.56%16.15B

12.10%15.01B

6.97%14.54B

1.55%14.96B

9.23%15.15B

4.32%13.39B

-Notes payable

3.54%3.65B

8.92%3.34B

11.58%3.85B

2.22%3.84B

2.66%3.53B

19.67%3.06B

5.78%3.45B

9.13%3.76B

27.16%3.44B

2.53%2.56B

-Accounts payable

0.58%12.69B

0.03%11.95B

1.78%11.29B

5.73%11.84B

7.70%12.62B

10.31%11.95B

7.35%11.09B

-0.77%11.2B

4.89%11.72B

4.75%10.83B

Contract liabilities

0.59%1.21B

3.52%1.45B

3.61%1.85B

-3.80%5.43B

4.24%1.2B

18.00%1.4B

17.28%1.78B

105.97%5.64B

-28.49%1.15B

-11.00%1.19B

Advance receipts

--5.25M

--5.96M

----

Salaries payable

-7.91%1.05B

-3.56%1.04B

-2.77%959.68M

5.91%1.07B

16.77%1.14B

13.71%1.08B

13.21%987M

6.25%1.01B

4.34%976.89M

10.11%947.45M

Taxs payable

-22.87%373.52M

4.99%443.41M

31.41%713.11M

2.89%386.55M

1.23%484.26M

-21.51%422.35M

2.60%542.67M

60.91%375.71M

11.90%478.37M

44.97%538.12M

Other payable (including interest and dividends)

32.01%6.28B

10.18%5.78B

5.31%5.49B

1.75%4.92B

7.58%4.76B

11.09%5.25B

14.12%5.22B

5.63%4.83B

-9.05%4.42B

17.88%4.72B

-Dividend payable

1,550.82%698.69M

-1.20%213.88M

0.65%54.76M

13.76%62.21M

-22.21%42.32M

5.40%216.47M

0.48%54.41M

-1.99%54.68M

-2.62%54.41M

18.01%205.38M

-Other payable

----

10.67%5.57B

----

11.35%5.03B

----

5.73%4.78B

----

17.88%4.52B

Non current liabilities due within one year

306.16%1.44B

-3.93%849.64M

-63.00%253.06M

-64.65%249.83M

-44.34%354.2M

249.45%884.43M

170.77%684.04M

187.52%706.73M

148.81%636.4M

8.64%253.09M

Other current liabilities

-67.47%144.21M

-66.60%153.79M

-55.11%228.24M

-47.50%695.88M

-39.86%443.24M

-37.79%460.48M

184.56%508.4M

282.99%1.33B

302.13%737.06M

397.26%740.22M

Total current liabilities

10.93%36.26B

3.64%34.25B

3.74%34.12B

-3.10%36.24B

2.19%32.69B

7.73%33.05B

5.44%32.89B

15.94%37.4B

2.46%31.99B

2.06%30.68B

Current liabilities

Long term loan

-15.57%2.65B

11.72%3.26B

11.90%3.51B

102.76%3.32B

78.84%3.13B

132.97%2.91B

316.63%3.14B

117.74%1.64B

128.16%1.75B

62.87%1.25B

Long term account payable

----

-3.46%19.67M

----

-0.12%20.37M

----

-0.33%20.4M

----

-0.33%20.4M

Long term salaries pay

-1.73%291.83K

-1.01%295.35K

-5.93%293.37K

-7.84%293.26K

-7.83%296.96K

-2.06%298.36K

3.33%311.86K

4.59%318.22K

3.94%322.2K

-1.61%304.66K

Estimate liabilities

4.62%59.35M

30.27%59.39M

26.49%55.7M

17.05%55.93M

27.37%56.73M

1.88%45.59M

-18.28%44.04M

-11.47%47.78M

-37.55%44.54M

-37.43%44.75M

Deferred tax liabilities

39.55%647.36M

1.20%655.99M

60.30%645.87M

62.08%639.53M

31.32%463.9M

84.69%648.18M

16.96%402.9M

18.95%394.59M

14.52%353.26M

16.35%350.95M

Long term deferred income

7.92%1B

10.47%1.02B

10.13%1.03B

7.57%1B

-5.74%929.99M

-2.32%923.89M

1.47%930.76M

12.59%930.93M

19.21%986.57M

12.92%945.81M

Lease liabilities

-18.83%512.3M

-6.85%538.16M

-3.48%559.51M

5.93%578.19M

32.47%631.14M

16.25%577.75M

17.14%579.67M

9.67%545.84M

-5.84%476.45M

-5.29%497M

Other non current liabilities

1.80%54.14M

1.73%54.18M

1.06%54.3M

2.69%54.7M

0.06%53.18M

-1.37%53.26M

-0.91%53.74M

-0.31%53.27M

-2.95%53.15M

-0.08%54M

Total non current liabilities

-6.56%4.94B

8.11%5.6B

13.58%5.87B

56.20%5.67B

43.46%5.29B

63.82%5.18B

95.90%5.17B

43.16%3.63B

44.06%3.69B

22.60%3.16B

Total liabilities

8.49%41.2B

4.24%39.85B

5.08%39.99B

2.15%41.91B

6.46%37.98B

12.97%38.23B

12.50%38.06B

17.93%41.03B

5.61%35.67B

3.68%33.84B

Shareholders equity

Paid-in capital

0.00%1.63B

Capital reserve funds

0.08%10.11B

0.00%10.11B

1.49%10.11B

0.73%9.96B

Surplus reserve funds

8.04%2.25B

8.08%2.25B

9.20%2.08B

10.95%1.91B

Retained profit

6.65%22.25B

12.11%22.29B

13.62%22.92B

14.77%20.96B

16.26%20.86B

16.54%19.88B

15.96%20.17B

17.15%18.26B

16.77%17.95B

17.19%17.06B

Other composite income

-1.45%-19.4M

-45.70%-19.37M

-21.97%-22.91M

-88.70%-24.34M

-129.24%-19.13M

-9.75%-13.29M

-0.97%-18.78M

26.18%-12.9M

56.52%-8.34M

44.23%-12.11M

Shareholders equity without minority interests

4.51%36.22B

7.65%36.26B

8.57%36.88B

8.90%34.92B

10.28%34.66B

10.30%33.69B

10.05%33.97B

10.33%32.07B

9.97%31.43B

9.98%30.54B

Minority interests

6.69%1.83B

9.67%1.85B

12.37%1.84B

11.81%1.76B

-29.97%1.72B

-30.15%1.69B

-30.38%1.63B

-30.55%1.57B

9.95%2.45B

10.40%2.42B

Total shareholder equity

4.61%38.05B

7.75%38.12B

8.74%38.71B

9.04%36.68B

7.37%36.38B

7.33%35.38B

7.19%35.6B

7.38%33.64B

9.96%33.88B

10.01%32.96B

Total liabilityies and equity

6.59%79.26B

5.93%77.97B

6.85%78.7B

5.25%78.59B

6.90%74.35B

10.19%73.61B

9.87%73.66B

12.93%74.67B

7.69%69.55B

6.71%66.8B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-13.52%17.19B	-22.31%16.23B	-2.43%19.75B	-5.29%21.31B	-8.30%19.87B	-7.37%20.89B	-14.12%20.25B	0.55%22.5B	-9.52%21.67B	2.07%22.55B
Transactional financial assets	-75.38%14M	-92.97%4M	-92.97%4M	-92.97%4M	12.24%56.87M	12.24%56.87M	468.73%56.87M	--56.87M	1,166.71%50.67M	153.34%50.67M
Notes receivable and accounts receivable	0.28%17.34B	1.36%17.41B	1.69%17.49B	-0.01%15.98B	5.81%17.3B	9.03%17.18B	13.66%17.2B	13.86%15.98B	14.93%16.35B	6.96%15.75B
-Notes receivable	-14.58%661.65M	-35.72%689.74M	-37.87%777.48M	-22.75%870.88M	-34.67%774.56M	-15.05%1.07B	-1.13%1.25B	-7.75%1.13B	28.51%1.19B	-3.89%1.26B
-Accounts receivable	0.97%16.68B	3.83%16.72B	4.79%16.72B	1.72%15.11B	8.97%16.52B	11.13%16.1B	15.01%15.95B	15.93%14.86B	13.99%15.16B	8.02%14.49B
Other receivables (including interest and dividends)	-9.93%971.41M	18.31%1.06B	-5.44%1.12B	-4.23%878.49M	3.19%1.08B	-18.08%895.1M	-4.76%1.18B	-22.18%917.24M	1.81%1.05B	4.93%1.09B
-Dividend receivable	-98.57%1.5M	-96.70%1.5M	-72.00%61.26M	-72.00%61.26M	-51.93%105.16M	-86.79%45.4M	-36.36%218.77M	-36.36%218.77M	45.84%218.77M	129.18%343.77M
-Other receivable	----	24.46%1.06B	----	----	----	13.46%849.7M	----	-16.34%698.48M	----	-15.98%748.91M
Advance payment	-24.42%648.23M	25.01%708.49M	95.23%982.77M	-2.12%818.36M	38.32%857.65M	-8.57%566.75M	-18.08%503.4M	7.29%836.05M	-10.83%620.05M	-1.61%619.87M
Inventories	17.46%11.34B	17.34%10.75B	10.10%9.85B	7.83%11.51B	14.43%9.66B	11.85%9.16B	2.45%8.95B	2.24%10.67B	-1.59%8.44B	0.37%8.19B
Receivable financing	32.20%3.69B	22.97%3.93B	9.02%5.08B	13.56%3.61B	6.86%2.79B	21.81%3.2B	33.68%4.66B	0.34%3.18B	-1.34%2.61B	-4.53%2.62B
Non-current assets due within one year	207.52%272.58M	-57.64%254.95M	-48.94%283.96M	-75.60%159.36M	-86.31%88.64M	451.75%601.9M	--556.08M	--653.12M	--647.53M	--109.09M
Other current assets	28.96%1.58B	24.88%1.6B	-33.04%1.4B	-24.42%1.71B	-13.98%1.22B	-14.66%1.28B	275.88%2.09B	173.39%2.26B	173.06%1.42B	194.65%1.5B
Total current assets	0.24%53.05B	-3.49%51.94B	0.94%55.96B	-1.89%55.98B	0.13%52.92B	2.54%53.82B	3.92%55.44B	8.05%57.06B	2.35%52.86B	5.13%52.49B
Non Current assets
Debt investment	46.62%9.57B	112.40%9.53B	69.37%6.45B	106.55%6.54B	122.56%6.53B	452.74%4.48B	346.58%3.81B	401.73%3.16B	369.29%2.93B	31.09%811.31M
Other equity investment	-0.67%104.4M	-1.35%104.19M	-5.46%104.48M	-5.26%103.81M	-9.69%105.1M	-15.83%105.62M	-12.34%110.51M	-11.22%109.57M	-27.82%116.38M	-22.29%125.48M
Other non-current financial assets	89.74%1.02B	-0.56%1.01B	-3.67%1.01B	-3.17%1.01B	-53.93%539.35M	0.32%1.01B	80.12%1.05B	80.89%1.04B	360.69%1.17B	307.63%1.01B
Investment real estate	11.36%147.66M	10.12%146.78M	-26.58%150.06M	-17.87%169.77M	-36.39%132.6M	-36.36%133.3M	-3.72%204.39M	-3.40%206.71M	-13.58%208.45M	-2.78%209.47M
Long-term equity investment	7.51%1.93B	-1.41%1.8B	23.62%1.83B	13.99%1.81B	8.38%1.79B	12.22%1.83B	-7.48%1.48B	1.36%1.58B	-11.54%1.65B	-11.26%1.63B
Fixed assets	----	13.92%4.42B	----	----	----	11.34%3.88B	----	10.80%3.71B	----	19.47%3.49B
Constru in process	----	25.06%2.69B	----	----	----	27.78%2.15B	----	34.80%2.11B	----	13.20%1.68B
Productive biological assets	-15.93%1.84M	-15.32%1.93M	-14.76%2.02M	-14.23%2.11M	-13.74%2.19M	-13.29%2.28M	-12.86%2.37M	-12.46%2.46M	-12.08%2.54M	-11.73%2.63M
Intangible assets	8.41%2.84B	8.61%2.86B	11.60%2.87B	11.66%2.89B	2.86%2.62B	2.74%2.63B	0.03%2.57B	0.10%2.59B	5.13%2.55B	5.50%2.56B
Development expenditure	38.53%366.38M	37.39%351.78M	31.98%333.02M	28.76%309.89M	1,811.46%264.48M	1,570.14%256.04M	1,832.90%252.33M	2,177.44%240.67M	54.00%13.84M	102.62%15.33M
Goodwill	0.17%830.85M	0.17%830.85M	0.00%829.47M	0.00%829.47M	0.00%829.47M	0.00%829.47M	0.00%829.47M	0.00%829.47M	0.47%829.47M	0.47%829.47M
Long deferred expense	-3.26%188.72M	3.69%184.89M	10.43%185.74M	13.84%189.88M	38.36%195.08M	27.11%178.31M	24.49%168.2M	25.91%166.8M	27.00%141M	24.71%140.28M
Deferred tax assets	24.33%1.17B	10.55%1.22B	33.50%1.19B	34.46%1.16B	15.69%940.69M	32.75%1.1B	12.38%892.5M	8.95%865.34M	5.82%813.13M	8.70%830.88M
Usufruct assets	-21.03%637.56M	-7.66%676.54M	-9.20%706.32M	-2.83%728.9M	16.50%807.35M	-3.88%732.66M	2.57%777.86M	-2.56%750.16M	-17.26%693.02M	-11.62%762.26M
Other non current assets	-54.22%206.17M	-54.05%210.45M	-6.77%212.67M	-63.96%86.45M	104.35%450.33M	112.09%458.04M	4.64%228.13M	42.35%239.83M	14.15%220.37M	18.24%215.97M
Total non current assets	22.29%26.21B	31.55%26.03B	24.82%22.74B	28.42%22.6B	28.36%21.43B	38.26%19.79B	33.02%18.22B	32.27%17.6B	28.99%16.69B	12.96%14.31B
Total assets	6.59%79.26B	5.93%77.97B	6.85%78.7B	5.25%78.59B	6.90%74.35B	10.19%73.61B	9.87%73.66B	12.93%74.67B	7.69%69.55B	6.71%66.8B
Liabilities
Current liabilities
Short term loan	15.36%9.41B	8.14%9.24B	9.98%9.48B	-8.66%7.8B	-3.20%8.16B	-3.96%8.55B	-10.85%8.62B	1.31%8.54B	-7.07%8.43B	-13.34%8.9B
Notes payable and accounts payable	1.23%16.35B	1.84%15.29B	4.11%15.14B	4.85%15.69B	6.56%16.15B	12.10%15.01B	6.97%14.54B	1.55%14.96B	9.23%15.15B	4.32%13.39B
-Notes payable	3.54%3.65B	8.92%3.34B	11.58%3.85B	2.22%3.84B	2.66%3.53B	19.67%3.06B	5.78%3.45B	9.13%3.76B	27.16%3.44B	2.53%2.56B
-Accounts payable	0.58%12.69B	0.03%11.95B	1.78%11.29B	5.73%11.84B	7.70%12.62B	10.31%11.95B	7.35%11.09B	-0.77%11.2B	4.89%11.72B	4.75%10.83B
Contract liabilities	0.59%1.21B	3.52%1.45B	3.61%1.85B	-3.80%5.43B	4.24%1.2B	18.00%1.4B	17.28%1.78B	105.97%5.64B	-28.49%1.15B	-11.00%1.19B
Advance receipts	--5.25M	--5.96M	----	----	----	----	----	----	----	----
Salaries payable	-7.91%1.05B	-3.56%1.04B	-2.77%959.68M	5.91%1.07B	16.77%1.14B	13.71%1.08B	13.21%987M	6.25%1.01B	4.34%976.89M	10.11%947.45M
Taxs payable	-22.87%373.52M	4.99%443.41M	31.41%713.11M	2.89%386.55M	1.23%484.26M	-21.51%422.35M	2.60%542.67M	60.91%375.71M	11.90%478.37M	44.97%538.12M
Other payable (including interest and dividends)	32.01%6.28B	10.18%5.78B	5.31%5.49B	1.75%4.92B	7.58%4.76B	11.09%5.25B	14.12%5.22B	5.63%4.83B	-9.05%4.42B	17.88%4.72B
-Dividend payable	1,550.82%698.69M	-1.20%213.88M	0.65%54.76M	13.76%62.21M	-22.21%42.32M	5.40%216.47M	0.48%54.41M	-1.99%54.68M	-2.62%54.41M	18.01%205.38M
-Other payable	----	10.67%5.57B	----	----	----	11.35%5.03B	----	5.73%4.78B	----	17.88%4.52B
Non current liabilities due within one year	306.16%1.44B	-3.93%849.64M	-63.00%253.06M	-64.65%249.83M	-44.34%354.2M	249.45%884.43M	170.77%684.04M	187.52%706.73M	148.81%636.4M	8.64%253.09M
Other current liabilities	-67.47%144.21M	-66.60%153.79M	-55.11%228.24M	-47.50%695.88M	-39.86%443.24M	-37.79%460.48M	184.56%508.4M	282.99%1.33B	302.13%737.06M	397.26%740.22M
Total current liabilities	10.93%36.26B	3.64%34.25B	3.74%34.12B	-3.10%36.24B	2.19%32.69B	7.73%33.05B	5.44%32.89B	15.94%37.4B	2.46%31.99B	2.06%30.68B
Current liabilities
Long term loan	-15.57%2.65B	11.72%3.26B	11.90%3.51B	102.76%3.32B	78.84%3.13B	132.97%2.91B	316.63%3.14B	117.74%1.64B	128.16%1.75B	62.87%1.25B
Long term account payable	----	-3.46%19.67M	----	----	----	-0.12%20.37M	----	-0.33%20.4M	----	-0.33%20.4M
Long term salaries pay	-1.73%291.83K	-1.01%295.35K	-5.93%293.37K	-7.84%293.26K	-7.83%296.96K	-2.06%298.36K	3.33%311.86K	4.59%318.22K	3.94%322.2K	-1.61%304.66K
Estimate liabilities	4.62%59.35M	30.27%59.39M	26.49%55.7M	17.05%55.93M	27.37%56.73M	1.88%45.59M	-18.28%44.04M	-11.47%47.78M	-37.55%44.54M	-37.43%44.75M
Deferred tax liabilities	39.55%647.36M	1.20%655.99M	60.30%645.87M	62.08%639.53M	31.32%463.9M	84.69%648.18M	16.96%402.9M	18.95%394.59M	14.52%353.26M	16.35%350.95M
Long term deferred income	7.92%1B	10.47%1.02B	10.13%1.03B	7.57%1B	-5.74%929.99M	-2.32%923.89M	1.47%930.76M	12.59%930.93M	19.21%986.57M	12.92%945.81M
Lease liabilities	-18.83%512.3M	-6.85%538.16M	-3.48%559.51M	5.93%578.19M	32.47%631.14M	16.25%577.75M	17.14%579.67M	9.67%545.84M	-5.84%476.45M	-5.29%497M
Other non current liabilities	1.80%54.14M	1.73%54.18M	1.06%54.3M	2.69%54.7M	0.06%53.18M	-1.37%53.26M	-0.91%53.74M	-0.31%53.27M	-2.95%53.15M	-0.08%54M
Total non current liabilities	-6.56%4.94B	8.11%5.6B	13.58%5.87B	56.20%5.67B	43.46%5.29B	63.82%5.18B	95.90%5.17B	43.16%3.63B	44.06%3.69B	22.60%3.16B
Total liabilities	8.49%41.2B	4.24%39.85B	5.08%39.99B	2.15%41.91B	6.46%37.98B	12.97%38.23B	12.50%38.06B	17.93%41.03B	5.61%35.67B	3.68%33.84B
Shareholders equity
Paid-in capital	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B	0.00%1.63B
Capital reserve funds	0.08%10.11B	0.08%10.11B	0.00%10.11B	0.00%10.11B	1.49%10.11B	1.49%10.11B	1.49%10.11B	1.49%10.11B	0.73%9.96B	0.73%9.96B
Surplus reserve funds	8.04%2.25B	8.04%2.25B	8.04%2.25B	8.08%2.25B	9.20%2.08B	9.20%2.08B	9.20%2.08B	9.20%2.08B	10.95%1.91B	10.95%1.91B
Retained profit	6.65%22.25B	12.11%22.29B	13.62%22.92B	14.77%20.96B	16.26%20.86B	16.54%19.88B	15.96%20.17B	17.15%18.26B	16.77%17.95B	17.19%17.06B
Other composite income	-1.45%-19.4M	-45.70%-19.37M	-21.97%-22.91M	-88.70%-24.34M	-129.24%-19.13M	-9.75%-13.29M	-0.97%-18.78M	26.18%-12.9M	56.52%-8.34M	44.23%-12.11M
Shareholders equity without minority interests	4.51%36.22B	7.65%36.26B	8.57%36.88B	8.90%34.92B	10.28%34.66B	10.30%33.69B	10.05%33.97B	10.33%32.07B	9.97%31.43B	9.98%30.54B
Minority interests	6.69%1.83B	9.67%1.85B	12.37%1.84B	11.81%1.76B	-29.97%1.72B	-30.15%1.69B	-30.38%1.63B	-30.55%1.57B	9.95%2.45B	10.40%2.42B
Total shareholder equity	4.61%38.05B	7.75%38.12B	8.74%38.71B	9.04%36.68B	7.37%36.38B	7.33%35.38B	7.19%35.6B	7.38%33.64B	9.96%33.88B	10.01%32.96B
Total liabilityies and equity	6.59%79.26B	5.93%77.97B	6.85%78.7B	5.25%78.59B	6.90%74.35B	10.19%73.61B	9.87%73.66B	12.93%74.67B	7.69%69.55B	6.71%66.8B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Dark Horse Technology Group

300688

40.90 +20.01%

Shenzhen L&A Design